Obstacles to human hematopoietic stem cell transduction by recombinant adeno-associated virus 2 vectors

This publication has 25 references indexed in Scilit:

• Adeno-Associated Virus Type 2-Mediated Gene Transfer: Altered Endocytic Processing Enhances Transduction Efficiency in Murine Fibroblasts
  Journal of Virology, 2001
• Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors
  Journal of General Virology, 2000
• Gene Therapy Using Hematopoietic Stem Cells: Sisyphus Approaches the Crest
  Human Gene Therapy, 2000
• Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38− subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV
  Gene Therapy, 2000
• Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'γ)2 antibody
  Nature Biotechnology, 1999
• Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
  Nature Medicine, 1999
• Transfer of Contaminants in Adeno-Associated Virus Vector Stocks Can Mimic Transduction and Lead to Artifactual Results
  Human Gene Therapy, 1997
• Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection
  Journal of General Virology, 1996
• Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells.
  Proceedings of the National Academy of Sciences, 1994
• Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
  Nature Genetics, 1994